Triple
T16851964
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Descovy |
E409695
|
entity |
| Predicate | indicationLimitation |
P99
|
FINISHED |
| Object | not indicated for PrEP in individuals at risk from receptive vaginal sex (per U.S. label as of 2024) |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: not indicated for PrEP in individuals at risk from receptive vaginal sex (per U.S. label as of 2024) | Statement: [Descovy, indicationLimitation, not indicated for PrEP in individuals at risk from receptive vaginal sex (per U.S. label as of 2024)]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: indicationLimitation Context triple: [Descovy, indicationLimitation, not indicated for PrEP in individuals at risk from receptive vaginal sex (per U.S. label as of 2024)]
-
A.
hasLimitation
chosen
Indicates that an entity is subject to a constraint, restriction, or boundary that limits its scope, capability, or applicability.
-
B.
showsLimitationOf
Indicates that one entity reveals, demonstrates, or makes apparent the limitations, weaknesses, or constraints of another entity.
-
C.
hasContraindication
Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
-
D.
treatmentIndication
Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
-
E.
reasonForPerformanceLimitation
Indicates that one factor serves as the cause or explanation for why a performance limitation occurs.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d88395e6c88190b22730f335107c14 |
completed | April 10, 2026, 4:59 a.m. |
| NER | Named-entity recognition | batch_69e3b379b8fc81908d8bc9950c7f8bad |
completed | April 18, 2026, 4:38 p.m. |
| PD | Predicate disambiguation | batch_69e32b8cbb048190878a259cc5be960e |
completed | April 18, 2026, 6:58 a.m. |
Created at: April 10, 2026, 5:24 a.m.